Precigen, Inc. (NASDAQ: PGEN) had its "overweight" rating re-affirmed by analysts at Cantor Fitzgerald.
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at HC Wainwright. They now have a $6.00 price target on the stock.
Precigen, Inc. (NASDAQ: PGEN) had its "buy" rating re-affirmed by analysts at Stifel Nicolaus. They now have a $7.00 price target on the stock.
Precigen, Inc. (PGEN) Reports Q1 Loss, Misses Revenue Estimates [Yahoo! Finance]
Precigen Reports First Quarter 2024 Financial Results and Business Updates [Yahoo! Finance]